Article: Nabi Biopharmaceuticals to Host Meeting on Innovations in Staph aureus Prevention and Treatment.

Article: Nabi Biopharmaceuticals Announces Pricing of Public Offering of 8,500,000 Shares of Common Stock at $10.00 Per Share.
PR Newswire;  December 18, 2003 ;     401 words ...Nabi Biopharmaceuticals today announced...December 23, 2003. Nabi Biopharmaceuticals intends to use...being offered by Nabi Biopharmaceuticals. In addition...common stock from Nabi Biopharmaceuticals to cover any...631-254-7268. About Nabi Biopharmaceuticals ...

Article: Nabi Biopharmaceuticals Acquires Full Rights to Aloprim(TM).
PR Newswire;  June 30, 2004 ;     700+ words ......contribute to Nabi Biopharmaceuticals' cash flow. Going forward, Nabi Biopharmaceuticals will benefit...hospital-based product. Nabi Biopharmaceuticals has particular...synergy in Nabi Biopharmaceuticals' hematology...communities allows Nabi ...

Article: Nabi Biopharmaceuticals' Altastaph(TM) Receives FDA Fast Track Designation.
PR Newswire;  March 3, 2004 ;     700+ words ......MD, PhD, Nabi Biopharmaceuticals' senior vice...affairs. Staph aureus infections...Vaccine), Nabi Biopharmaceuticals' investigational...to prevent Staph aureus infections...StaphVAX, Nabi Biopharmaceuticals vaccine against Staph aureus ...

Article: Nabi Biopharmaceuticals Receives FDA Orphan Drug Designation for Altastaph(TM); - Altastaph, Currently in Phase II Trials, is Designed to Provide Immediate Protection Against Staph aureus Infections in Low Birth-Weight Infants -.
PR Newswire;  February 11, 2004 ;     700+ words ......MD, PhD, Nabi Biopharmaceuticals' senior vice...affairs. Staph aureus infections...Vaccine), Nabi Biopharmaceuticals' investigational...to prevent Staph aureus infections...StaphVAX, Nabi Biopharmaceuticals vaccine against Staph aureus ...

Article: Nabi Biopharmaceuticals to Announce Second Quarter 2004 Financial Results on July 21, 2004.
PR Newswire;  July 1, 2004 ;     536 words ...Nabi Biopharmaceuticals will release...July 21, 2004. Nabi Biopharmaceuticals management will...accessed via the Nabi Biopharmaceuticals website at http...available on the Nabi Biopharmaceuticals website. About Nabi Biopharmaceuticals Nabi ...

Article: Nabi Biopharmaceuticals to Announce First Quarter 2004 Financial Results on April 21, 2004.
PR Newswire;  April 6, 2004 ;     542 words ...Nabi Biopharmaceuticals will release...April 21, 2004. Nabi Biopharmaceuticals management will...accessed via the Nabi Biopharmaceuticals website at http...available on the Nabi Biopharmaceuticals website. About Nabi Biopharmaceuticals Nabi ...

Article: Nabi Biopharmaceuticals Announces New Date for Second Quarter 2004 Financial Results.
PR Newswire;  July 16, 2004 ;     552 words ......July 20, 2004 ~ Nabi Biopharmaceuticals announced today...July 20, 2004. Nabi Biopharmaceuticals management will...accessed via the Nabi Biopharmaceuticals website at http...available on the Nabi Biopharmaceuticals website. About Nabi Biopharmaceuticals ...

Article: Nabi Biopharmaceuticals To Present At US Bancorp Piper Jaffray Healthcare Conference.
PR Newswire;  January 21, 2004 ;     471 words ...Nabi Biopharmaceuticals announced today that...conference via replay at the Nabi Biopharmaceuticals website: http://www.nabi.com/ About Nabi Biopharmaceuticals Nabi Biopharmaceuticals applies its knowledge...products (PhosLo(R), Nabi- HB(R), WinRho ...

Article: Nabi Biopharmaceuticals Completes Common Stock Offering, Underwriters Exercise Overallotment Option.
PR Newswire;  December 29, 2003 ;     663 words ...Nabi Biopharmaceuticals today announced the...development for preventing Staph aureus blood stream infections...Thomas H. McLain, Nabi Biopharmaceuticals CEO and president...marketed products (Nabi-HB(R), PhosLo(R...prevalent strains of Staph aureus bacterial ...

Article: Staph aureus Blood Stream Infection in End Stage Kidney Disease Associated With Substantial Illness and Increased Healthcare Costs; Pharmacoeconomic Studies Sponsored by Nabi Biopharmaceuticals Presented at 43rd Annual ICAAC Meeting.
PR Newswire;  September 17, 2003 ;     700+ words ......methicillin sensitive Staph aureus (MSSA). The...sponsored by Nabi Biopharmaceuticals, Inc. and executed...Durham, NC. Staph aureus is the most...M.D., Ph.D., Nabi Biopharmaceuticals senior vice...trying to manage Staph aureus bacteremias...approach such ...

Article: Nabi Biopharmaceuticals to Announce Fourth Quarter and Year-End Financial Results for 2003 on February 18, 2004; Date of Annual Stockholders Meeting Set for May 14, 2004.
PR Newswire;  January 20, 2004 ;     518 words ...Nabi Biopharmaceuticals will issue a...the webcast, Nabi Biopharmaceuticals management will...accessed via the Nabi Biopharmaceuticals website at: http...company's website. Nabi Biopharmaceuticals also announced...2004. About Nabi Biopharmaceuticals ...

Article: Nabi Biopharmaceuticals To Present At BIO CEO & Investor Conference.
PR Newswire;  February 23, 2004 ;     606 words ...Nabi Biopharmaceuticals announced today that...conference via replay at the Nabi Biopharmaceuticals' website: http://www...ajwz400265501gf12.html About Nabi Biopharmaceuticals Nabi Biopharmaceuticals applies its knowledge...products (PhosLo(R), Nabi- HB(R), WinRho ...

Article: Nabi Biopharmaceuticals To Present At Lehman Brothers Seventh Annual Global Healthcare Conference.
PR Newswire;  March 3, 2004 ;     520 words ...Nabi Biopharmaceuticals announced today that...conference via replay at the Nabi Biopharmaceuticals website. About Nabi Biopharmaceuticals Nabi Biopharmaceuticals applies its knowledge...products (PhosLo(R), Nabi- HB(R), WinRho SDF(R...and clinical testing. ...

Article: Nabi Biopharmaceuticals to Present at the White Mountain Capital Second Annual Biotechnology Conference.
PR Newswire;  April 20, 2004 ;     523 words ...Nabi Biopharmaceuticals announced today that...the conference at the Nabi Biopharmaceuticals website. About Nabi Biopharmaceuticals Nabi Biopharmaceuticals applies its knowledge...products (PhosLo(R), Nabi- HB(R), WinRho SDF(R...and clinical testing. Nabi ...